富国恒生港股通创新药及医疗保健ETF(159506)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
7,188,117.28 |
15,721.36 |
25.11 |
58,294,763.08 |
| 存出保证金 |
90,295.06 |
4,790.27 |
14.81 |
4,268,634.41 |
| 交易性金融资产 |
2,192,016,413.78 |
546,507,858.49 |
377,305,125.09 |
395,096,959.24 |
| 其中:股票投资 |
2,192,016,413.78 |
546,507,858.49 |
377,305,125.09 |
395,096,959.24 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
- |
17.04 |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
3,903,897.37 |
3,476,704.73 |
1,725,602.48 |
- |
| 应收申购款 |
- |
- |
- |
- |
| 其他资产 |
- |
- |
75,409.61 |
- |
| 资产总计 |
2,222,295,206.65 |
550,944,553.67 |
381,543,374.63 |
553,972,493.06 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
15,345,387.06 |
484.98 |
604,326.05 |
155,770,087.45 |
| 应付赎回款 |
- |
- |
- |
- |
| 应付管理人报酬 |
869,117.20 |
212,943.33 |
157,615.76 |
91,373.53 |
| 应付托管费 |
173,823.43 |
42,588.67 |
31,523.12 |
18,274.71 |
| 应付销售服务费 |
- |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
283,889.37 |
74,182.45 |
141,124.88 |
130,861.79 |
| 负债合计 |
16,672,217.06 |
330,199.43 |
934,589.81 |
156,010,597.48 |
| 所有者权益 |
| 实收基金 |
1,764,536,979.00 |
682,536,979.00 |
545,536,979.00 |
417,536,979.00 |
| 未分配利润 |
441,086,010.59 |
-131,922,624.76 |
-164,928,194.18 |
-19,575,083.42 |
| 所有者权益合计 |
2,205,622,989.59 |
550,614,354.24 |
380,608,784.82 |
397,961,895.58 |
| 负债及所有者权益总计 |
2,222,295,206.65 |
550,944,553.67 |
381,543,374.63 |
553,972,493.06 |